Hamrosi Kim K, Raynor David K, Aslani Parisa
Faculty of Pharmacy, Pharmacy & Bank Building A15, University of Sydney, Sydney, NSW 2006, Australia.
School of Healthcare, University of Leeds, Leeds, UK.
Res Social Adm Pharm. 2014 Jul-Aug;10(4):656-68. doi: 10.1016/j.sapharm.2013.10.002. Epub 2013 Oct 12.
Providing written medicine information to consumers enables them to make informed decisions about their medicines, playing an important role in educating and improving health literacy. In Australia, standardized written medicine information called Consumer Medicine Information (CMI) is available for medicines as package inserts, computer prints, or leaflets. Consumers want and read CMI, but may not always ask for it. General practitioners (GPs) and pharmacists are an important source of written medicine information, yet may not always provide CMI in their practice.
To examine and compare the awareness, use and provision of CMI by consumers, pharmacists and general practitioners (GPs).
Based on previous studies, structured questionnaires were developed and administered to a national sample of consumers (phone survey); community pharmacists and GPs (postal surveys) about utilization of CMI. Descriptive, comparative and logistic regression analyses were conducted.
The respondents comprised of 349 pharmacists, 181 GPs and 1000 consumers. Two-thirds of consumers, nearly all (99%) pharmacists and 90% of GPs were aware of CMI. About 88% of consumers reported receiving CMI as a package insert, however most pharmacists (99%) and GPs (56%) reported providing computer-generated CMI. GPs' and pharmacists' main reason for providing CMI was on patient request. Reasons for not providing were predominantly because consumers were already taking the medicine, concerns regarding difficulty understanding the information, or potential non-adherence. Of the 691 consumers reportedly reading CMI, 35% indicated concerns after reading. Factors associated with reading included gender, type of CMI received and frequency of provision.
Consumers want and read information about their medicines, especially when received from their GP or pharmacist. Healthcare professionals report usually discussing CMI when providing it to patients, although continued improvements in dissemination rates are desirable. Regular use of CMI remains a challenge, and ongoing strategies to promote CMI use are necessary to improve uptake of CMI in Australia.
向消费者提供书面药品信息能使他们对自己的药物做出明智的决策,在教育和提高健康素养方面发挥重要作用。在澳大利亚,名为消费者药品信息(CMI)的标准化书面药品信息以包装插页、电脑打印件或传单的形式提供给药品。消费者想要并阅读CMI,但可能并不总是主动索要。全科医生(GP)和药剂师是书面药品信息的重要来源,但在实际工作中可能并不总是提供CMI。
调查并比较消费者、药剂师和全科医生(GP)对CMI的知晓度、使用情况和提供情况。
根据以往研究,设计了结构化问卷,并对全国范围内的消费者样本(电话调查)、社区药剂师和全科医生(邮寄调查)进行了关于CMI使用情况的调查。进行了描述性、比较性和逻辑回归分析。
受访者包括349名药剂师、181名全科医生和1000名消费者。三分之二的消费者、几乎所有(99%)的药剂师和90%的全科医生知晓CMI。约88%的消费者报告收到过作为包装插页的CMI,然而大多数药剂师(99%)和全科医生(56%)报告提供的是电脑生成的CMI。全科医生和药剂师提供CMI的主要原因是患者要求。不提供的主要原因主要是消费者已经在服用该药物、担心难以理解信息或可能出现不依从情况。在据报道阅读过CMI的691名消费者中,35%表示阅读后存在担忧。与阅读相关的因素包括性别、收到的CMI类型和提供频率。
消费者想要并阅读有关其药物的信息,尤其是从他们的全科医生或药剂师那里获得时。医疗保健专业人员报告说,在向患者提供CMI时通常会进行讨论,尽管传播率仍需持续提高。CMI的定期使用仍然是一个挑战,需要持续的策略来促进CMI的使用,以提高澳大利亚对CMI的接受程度。